BioSpace News Archive

Business

GE Healthcare and SOPHiA GENETICS to collaborate to match treatments to multimodal patient data and cancer type

GE Healthcare and SOPHiA GENETICS announced that they have signed a letter of intent to collaborate on advancing cancer care, with the goal of better targeting and matching treatments to each patient’s genomic profile and cancer type, helping to ensure the most effective and personalized treatment.

July 6, 2021
·
6 min read
Deals

Treo Ventures Announces the Successful IPO of its Portfolio Company CVRx® (NSDQ: CVRX)

Treo Ventures portfolio company CVRx, Inc. announced the upsized pricing of its initial public offering on the Nasdaq Global Select Market.

July 6, 2021
·
2 min read
FDA

CytoSorbents Receives Full FDA Approval of Investigational Device Exemption (IDE) for U.S. STAR-T Trial on Ticagrelor Removal During Cardiothoracic Surgery

CytoSorbents Corporation announces the full approval of its Investigational Device Exemption application to conduct the pivotal STAR-T double-blind, randomized, controlled trial in the United States to support FDA regulatory clearance.

July 6, 2021
·
8 min read
Genetown

Allurion Technologies Unveils Transformed Allurion™ Weight Loss Program and New Corporate Brand

Allurion Technologies announced today two major milestones with the launch of the transformed Allurion Weight Loss Program and new worldwide brand for the company and its program.

July 6, 2021
·
3 min read
Genetown

Apnimed to Present at the Ladenburg Thalmann Virtual Healthcare Conference

Apnimed, a clinical-stage pharmaceutical company focused on developing oral medicines to treat Obstructive Sleep Apnea and related disorders, announced that the Company’s management team will participate in the Ladenburg Thalmann Virtual Healthcare Conference, held July 13-14, 2021.

July 6, 2021
·
2 min read
Genetown

Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - July 06, 2021

Verastem Oncology, a biopharmaceutical company committed to advancing new medicines for patients battling cancer, announced the grant of options to purchase 16,250 shares of its common stock and the grant of 8,125 restricted stock units to three new employees.

July 6, 2021
·
1 min read
Drug Development

4D pharma Announces Publication of Preclinical Research Showing Single Strain Megasphaera massiliensis improves activity of CAR-T

4D pharma plc today announces the publication of pre-clinical research relating to its second-generation immuno-oncology LBP MRx1299 improving the activity of CAR-T.

July 6, 2021
·
6 min read
Business

Cybin Enters into Collaboration Agreement with Greenbrook TMS to Establish Mental Health Centers of Excellence

Cybin Inc. today announced that it has entered into an exclusive research and development collaboration agreement (the “ Collaboration Agreement ”) with TMS NeuroHealth Centers Inc., a wholly-owned subsidiary of Greenbrook TMS Inc.

July 6, 2021
·
6 min read
Pharm Country

Immunome to Present at the Ladenburg Thalmann 2021 Healthcare Conference

Immunome, Inc. today announced that Purnanand Sarma, Ph.D., Immunome’s President and CEO, will present at the Ladenburg Thalmann 2021 Healthcare Conference on Tuesday, July 13, 2021, at 10:30 a.m. ET.

July 6, 2021
·
3 min read
Alvotech Initiates Clinical Studies for AVT04, a Proposed Biosimilar to Stelara® (Ustekinumab)

Alvotech today announced that the first patient has been dosed in the comparative, confirmatory efficacy and safety clinical study (AVT04-GL-301) for AVT04.

July 6, 2021
·
5 min read